News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Addressing effects of breast cancer among the workforce

Addressing the growing effects of breast cancer among the workforce - Economist Report


Please find attached an Economist Intelligence Unit report on how to address the growing effects of breast cancer among the New Zealand workforce.

In a few weeks time PHARMAC is due to make a decision on funding new treatments which can give New Zealand women with metastatic breast cancer a better quality of life and more time with their loved ones.

MedSafe NZ has approved the use of Ibrance (palbociclib) for those with advanced hormone receptor positive and HER2-negative breast cancer, but it’s only available to those who can pay for it.
The medicine is a breakthrough drug and preliminary clinical evidence for it was so strong that the United States Food and Drug Administration fast-tracked its use in that country.

Breast Cancer Aotearoa Coalition chairperson Libby Burgess says hundreds of women could potentially benefit from Ibrance now that it is available in New Zealand.

'This medicine is a game changer for women with hormone receptor positive, but HER2- negative breast cancer. It will give them a better quality of life and more time with their loved ones.'

Richard Egan of the University of Otago says 'As cancer has gone from what people used to unfairly think was a death sentence to a chronic disease, we’re starting to think more about survivors, people living well with cancer and past cancer. That change affects individuals, public health and the economy. Survivorship is impacting the rest of society.'

He points out as survival rates improve thanks to earlier detection and improved treatment, there is a need to address the growing effects of breast cancer among the workforce.

EIU_Pfizer_New_Zealand_breast_cancer_returntowork_layout.pdf



© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Howard Davis Review: Voulez-Vous Couchez Avec Moi? - C'est Chic, Ça Colette!

Starring the ravishingly vibrant Keira Knightley in the title role, Colette is a fairly pedestrian paint-by numbers biopic - which is a little disappointing, given that its cross-dressing and pansexual protagonist lead anything but a dull life. More>>


Wellington Repertory Theatre: New Season Includes Royal Hunt of The Sun

“The objective behind our ambitious 2019 season is to expand our offering to a broader range of Wellingtonians. It’s the first time in over a decade that we’ve produced four shows, and the first time we will be performing at the Hannah Payhouse,” says Oliver Mander, WRT’s President. More>>


Howard Davis Review: The Revenants - They Shall Not Grow Old

Jackson has toiled laboriously in the trenches of the digital revolution for decades, with his two turgid Tolkien trilogies constantly pushing the envelope in terms of computer-generated entertainment and providing his latest project with sufficient combat experience to warrant serious Oscar consideration for its remarkable technical achievements. More>>


Unseen Let It Be Footage: Peter Jackson Making "The Ultimate Beatles Film"

Jackson's new film will be compiled from fifty-five hours of never-released studio footage of The Beatles recording their final album Let It Be in January 1969. More>>


NZCT Grants More Than $150,000 to Community Sports

NZCT has approved grants to the Tauranga Boxing Academy, provided a new lease of life to old yachts, benefitted sports at Tiniroto School, and helped to upgrade Christchurch City BMX Club track. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland